Medicare Enrolled

Dr. Robin Lucas, MD

Critical Care Medicine · Somerset, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
35 CLYDE RD, Somerset, NJ 08873
7328739682
In practice since 2005 (20 years)
NPI: 1841286697 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lucas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lucas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lucas

Dr. Robin Lucas is a critical care medicine specialist in Somerset, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lucas performed 1,369 Medicare services across 782 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lucas received a total of $26,728 from 30 pharmaceutical and/or device companies across 372 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lucas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 32% volume in NJ $26,728 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,369
Medicare services
Top 32% in NJ for critical care medicine
782
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~68 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
784 $70 $594
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
116 $42 $325
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
98 $34 $291
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
93 $51 $393
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
72 $39 $298
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
54 $132 $1,098
Albuterol inhalation solution, 1 mg
A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation.
33 $0 $1
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
28 $8 $64
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $106 $856
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
17 $44 $337
Arformoterol inhalation solution, 15 mcg
A unit dose of FDA-approved arformoterol inhalation solution administered through durable medical equipment.
17 $2 $20
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
16 $30 $226
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
15 $96 $852
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$26,728
Total received (2018-2024)
Avg $3,818/year across 7 years
Top 5% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
372
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,165 (82.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,563 (17.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,780
2023
$7,074
2022
$1,154
2021
$579
2020
$214
2019
$656
2018
$10,270

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$6,429
Mylan Specialty L.P.
$89
GlaxoSmithKline, LLC.
$76
GENZYME CORPORATION
$53
Novo Nordisk Inc
$35
Genentech USA, Inc.
$35
Merck Sharp & Dohme LLC
$17
Regeneron Healthcare Solutions, Inc.
$17
Lilly USA, LLC
$15
Dentsply Sirona Inc
$15
Top 3 companies account for 97.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$12,677
Bayer HealthCare Pharmaceuticals Inc.
$5,788
Gilead Sciences, Inc.
$4,078
GlaxoSmithKline, LLC.
$1,160
Mylan Specialty L.P.
$664
Genentech USA, Inc.
$455
Novo Nordisk Inc
$285
Philips Electronics North America Corporation
$257
United Therapeutics Corporation
$151
GENZYME CORPORATION
$150
Allergan Inc.
$120
Novartis Pharmaceuticals Corporation
$101
Amgen Inc.
$98
Sunovion Pharmaceuticals Inc.
$85
Regeneron Healthcare Solutions, Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
PFIZER INC.
$60
Mallinckrodt LLC
$57
Grifols USA, LLC
$50
Abbott Laboratories
$48
ANI Pharmaceuticals, Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$45
Mallinckrodt Hospital Products Inc.
$41
Exeltis, USA Inc.
$35
Merck Sharp & Dohme LLC
$34
Lilly USA, LLC
$30
Amarin Pharma Inc.
$27
Dentsply Sirona Inc
$15
Janssen Pharmaceuticals, Inc
$14
SANOFI-AVENTIS U.S. LLC
$13
Top 3 companies account for 84.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · AVYCAZ · Adempas · BEVESPI AEROSPHERE · BREO ELLIPTA · BREZTRI · DUPIXENT · Dymista · ELIQUIS · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · JARDIANCE · LONHALA MAGNAIR · NUCALA · OFEV · ORENITRAM · Ozempic · PURIFIED CORTROPHIN GEL · Prime&Bond NT Nano-Technology Light Cured Dental Adhesive · Prolastin-C Liquid · Rybelsus · SPIRIVA RESPIMAT · SYMBICORT · Saxenda · TAGRISSO · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TYVASO · UTIBRON NEOHALER · Vascepa · WINREVAIR · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for critical care medicine in NJ.

Looking for a critical care medicine specialist in Somerset?
Compare critical care medicines in the Somerset area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
89
Per 100K population
25.7
County median income
$135,960
Nearest hospital
UNIVERSITY BEHAVIORAL HEALTH CARE
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lucas is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lucas experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lucas performed 784 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lucas receive payments from pharmaceutical companies?
Yes. Dr. Lucas received a total of $26,728 from 30 companies across 372 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lucas's costs compare to other critical care medicines in Somerset?
Dr. Lucas's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lucas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →